8.68
price down icon3.02%   -0.27
 
loading
Precedente Chiudi:
$8.95
Aprire:
$8.9
Volume 24 ore:
16,361
Relative Volume:
0.40
Capitalizzazione di mercato:
$749.78M
Reddito:
$213.45M
Utile/perdita netta:
$-72.46M
Rapporto P/E:
-8.7359
EPS:
-0.9936
Flusso di cassa netto:
$-47.28M
1 W Prestazione:
-2.47%
1M Prestazione:
-5.55%
6M Prestazione:
+41.14%
1 anno Prestazione:
+120.87%
Intervallo 1D:
Value
$8.68
$8.91
Intervallo di 1 settimana:
Value
$8.62
$9.18
Portata 52W:
Value
$3.62
$12.25

Valneva Se Adr Stock (VALN) Company Profile

Name
Nome
Valneva Se Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
713
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-21
Name
Ultimi documenti SEC
Name
VALN's Discussions on Twitter

Confronta VALN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VALN
Valneva Se Adr
8.68 773.10M 213.45M -72.46M -47.28M -0.9936
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Valneva Se Adr Stock (VALN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-19 Ripresa H.C. Wainwright Buy
2022-08-03 Iniziato H.C. Wainwright Buy

Valneva Se Adr Borsa (VALN) Ultime notizie

pulisher
Dec 11, 2025

Valneva stock rises after positive final Phase 2 results for chikungunya vaccine - Investing.com

Dec 11, 2025
pulisher
Dec 05, 2025

VALNEVA Declaration of shares and voting rights: November 30, 2025 - GlobeNewswire Inc.

Dec 05, 2025
pulisher
Nov 29, 2025

Valneva (NASDAQ:VALN) Stock Price Down 3.1%What's Next? - MarketBeat

Nov 29, 2025
pulisher
Nov 27, 2025

Valneva (NASDAQ:VALN) Sees Strong Trading VolumeHere's What Happened - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

Valneva stock rises after positive Lyme disease vaccine booster data - Investing.com

Nov 26, 2025
pulisher
Nov 14, 2025

Valneva SE earnings beat by $0.02, revenue fell short of estimates - Investing.com

Nov 14, 2025
pulisher
Nov 13, 2025

Valneva (VALN) Projected to Post Earnings on Thursday - MarketBeat

Nov 13, 2025
pulisher
Nov 12, 2025

Disney, Brookfield, Nu Holdings and more set to report earnings Thursday - Investing.com

Nov 12, 2025
pulisher
Nov 08, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SEVALN - 2822news.com

Nov 08, 2025
pulisher
Nov 06, 2025

Free cash flow per share of Valneva SE Sponsored ADR – LS:A3CPD1 - TradingView

Nov 06, 2025
pulisher
Oct 28, 2025

Valneva SE Sponsored ADR (NASDAQ:VALN) Short Interest Update - MarketBeat

Oct 28, 2025
pulisher
Oct 25, 2025

Valneva's (VALN) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat

Oct 25, 2025
pulisher
Oct 21, 2025

Valneva (NASDAQ:VALN) Trading Down 0.8%Time to Sell? - MarketBeat

Oct 21, 2025
pulisher
Oct 21, 2025

Valneva (NASDAQ:VALN) Trading Down 0.8% – Time to Sell? - Defense World

Oct 21, 2025
pulisher
Oct 11, 2025

Valneva (NASDAQ:VALN) Stock Price Down 4.9%Here's Why - MarketBeat

Oct 11, 2025
pulisher
Oct 09, 2025

Kepler Capital Sticks to Its Buy Rating for Valneva (0OB3) - Barchart.com

Oct 09, 2025
pulisher
Oct 09, 2025

Valneva–Aktie: Finanzierung gesichert, Erwartungen gesenkt! - Finanztrends

Oct 09, 2025
pulisher
Oct 07, 2025

Valneva (NASDAQ:VALN) Shares Gap DownWhat's Next? - MarketBeat

Oct 07, 2025
pulisher
Oct 07, 2025

Valneva stock falls after FDA suspension forces guidance cut - Investing.com

Oct 07, 2025
pulisher
Sep 30, 2025

Valneva’s Ixchiq shows 95% 4-year antibody persistence, shares up 10% - Investing.com

Sep 30, 2025
pulisher
Sep 29, 2025

Valneva (NASDAQ:VALN) Shares Gap UpHere's What Happened - MarketBeat

Sep 29, 2025
pulisher
Sep 19, 2025

VALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Sep 19, 2025
pulisher
Sep 17, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Sep 17, 2025
pulisher
Sep 16, 2025

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Sep 16, 2025
pulisher
Sep 15, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Sep 15, 2025
pulisher
Sep 15, 2025

Valneva (NASDAQ:VALN) Trading 5.6% HigherShould You Buy? - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Shareholders to Connect - ACCESS Newswire

Sep 14, 2025
pulisher
Sep 12, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Sep 12, 2025
pulisher
Sep 12, 2025

Valneva SE Sponsored ADR (NASDAQ:VALN) Short Interest Down 81.3% in August - Defense World

Sep 12, 2025
pulisher
Sep 12, 2025

Valneva SE Sponsored ADR (NASDAQ:VALN) Short Interest Up 64.6% in August - MarketBeat

Sep 12, 2025
pulisher
Sep 11, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Sep 11, 2025

Valneva Se Adr Azioni (VALN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Capitalizzazione:     |  Volume (24 ore):